trial with title Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

Have you been Diagnosed with
Atopic Dermatitis (Eczema)?

Participate in a Clinical Research Study

Conducted by

Logo

Study Summary

This study is enrolling participants in a clinical research study to evaluate an investigational cream for adolescents and adults with atopic dermatitis (eczema).


Eligible participants will receive expert care for their condition as well as study cream or placebo at no cost. Compensation for travel and time may be available to study participants. 


Eligibility Requirements

Inclusion Criteria:
  1. Participants legally competent to sign and give informed consent and, if appropriate, assent as required by local laws
  2. Males and females, ages 6 years and older 
  3. Have atopic dermatitis for at least 6 months (3 months for children)
  4. Stable disease for the past 4 weeks with no significant flares in atopic dermatitis before screening

Additional Information

  • Condition: Dermatite Atopique, ATOPIC DERMATITIS, Eczema (Atopic Dermatitis), Atopic, Dermatitis, Eczema (Atopic Dermatitis - Pediatric), Hand Dermatitis, Eczéma (Dermatite Atopique), Atopic Dermatitis, Dermatitis, Atopic
  • Gender: Both
  • Age: 6-100
  • Phase: Phase 3
  • Status: Not Recruiting
  • Start Date: 01/27/2021
  • End Date: 11/01/2022
  • Last Updated: 06/08/2021